The European Commission has granted a conditional marketing authorisation (CMA) for the COVID‑19 vaccine Nuvaxovid, developed by Novavax, the fifth COVID-19 vaccine authorised in the EU. This authorisation follows a positive scientific recommendation based on a thorough assessment of the safety, effectiveness and quality of the vaccine by the European Medicines Agency (EMA) and is…
Consider this: on the day the UK announced it had given the coronavirus jab to 1.5m of its citizens, there were some EU member states yet to vaccinate a single one of their citizens. These included The Netherlands, which has always prided itself on its healthcare system but neighbouring Belgium also pretty much matched the…
The European Commission on Friday proposed to the EU Member States to purchase an additional 200 million doses of the COVID-19 vaccine produced by BioNTech and Pfizer, with the option to acquire another 100 million doses. This would enable the EU to purchase up to 600 million doses of this vaccine, which is already…
